Defense World
24 Jan 2026, 10:22 UTC · 34w ago
Verdict
Headline takes no side. We score FOLD −0.20 across two claims — slightly bearish.
−0.20slightly bearish
More negative than 75% of ticker scores this week
What the story claims
2 claims · scored −1 bearish … +1 bullish
Amicus Therapeutics CEO Bradley Campbell sold 75,000 shares of company stock on January 20th.
More negative than 70% of claims this week
The CEO retains a significant ownership stake of 1,021,180 shares following the sale.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 40% of claims this week
Which stocks this story touches
More negative than 75% of ticker scores this week
The CEO sold a significant amount of shares, which is often interpreted as a bearish signal by investors.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+1.5%
Price is moving against the score
$14.49 vs $14.27 close before publication (Jan 23) · not market-adjusted
FOLD chart →
